TNF and juvenile idiopathic arthritis: These anti-TNF biologics are currently used successfully for the clinical treatment of RA, JIA, PsA, ankylosing spondylitis, psoriasis, and forms of IBD, particularly Crohn’s disease (CD) and ulcerative colitis (UC) (Mitoma et al., 2018).